AR and triple-negative breast carcinoma: However, AR expression in estrogen receptor-negative (ER-negative) subtypes, including triple-negative breast cancer (TNBC), is less clearly understood, and its role in promoting tumorigenesis and metastasis in these cases remains controversial.